LARVOL is pleased to present a moderated discussion with top oncologists following the ESMO Congress 2021. In the video below, Dr. Diwakar Davar, Dr. Pauline Funchain and Dr. Jennifer McQuade discuss the practice-changing impact of ESMO presentations in Melanoma.
On September 20th, 2021, LARVOL hosted an Oncology Panel to discuss the top Melanoma clinical trial abstracts presented during the ESMO Congress 2021 , held on September 16-21, 2021. Dr. Diwakar Davar from UPMC Hillman Cancer Center moderated the discussion between Melanoma experts Dr. Pauline Funchain from Taussig Cancer Institute at Cleveland Clinic and Dr. Jennifer McQuade from MD Anderson Cancer Center.
The discussion covered ESMO Melanoma Abstracts:
Watch this video for the full discussion:
The advent of precision oncology is marked by many new changes and improvements in diagnostic, prognostic and treatment methods for cancer patients. Researchers looking to bring new drugs to market are now also privy to a vast database of material from previously conducted studies thanks to a push forward in research collaborations and the creation of shared data hubs.